Vaibhav Singh

Vaibhav Singh is a Middle Office Analyst at Walleye Capital since July 2024, with previous experience as an Operations Analyst at Sculptor Capital Management from February 2022 to June 2024, and as an Operations Support Analyst at Morgan Stanley from June 2021 to February 2022. Vaibhav also completed an internship in Data Product Services at Nasdaq in 2020 and served as a Werner H. Kirsten Student Intern at the National Cancer Institute from June 2016 to August 2017, where notable contributions included mentoring new interns and utilizing CRISPR/Cas9 for gene editing. Vaibhav holds a Bachelor of Arts in Economics from the University of Maryland, graduated in 2021.